Pesticides
Herbicides: Glyphosate, Methotrexate, Triazine, Others
Insecticides: Pyrethroids and Abamectin, Others
Fungicides: Triazole, Azoxystrobin and Carbendazim, Others
Biopesticides
Rodenticides, Plant Growth Regulators, Adjuvants
Nature of Pesticides
Generic
Patented
https://www.businesswire.com/news/home/20190225005453/en/South-African-Crop-Protection-Market-by-Type-Nature-Form-of-Pesticide-Type-of-Crop-and-Market-Structure---Forecast-to-2022---ResearchAndMarkets.com
HPLC Analysis of Polyglutamate Metabolites of Methotrexate on TSKgel® NH2-100 and ODS-100V
Separation of Methotrexate (MTX)-PG; Methotrexate (MTX)-PG2; Methotrexate (MTX)-PG3 ; Methotrexate (MTX)-PG4; Methotrexate (MTX)-PG5; Methotrexate (MTX)-PG6; Methotrexate (MTX)-PG7
https://www.sigmaaldrich.com/US/en/search/90-15-3?focus=sitecontent&page=1&perPage=30&sort=relevance&term=90-15-3&type=site_content
Preparation of Cationic Liposomes & Transfection of Cells - Avanti® Polar Lipids
This procedure describes the Preparation of Cationic Liposomes & Transfection of Cells
Caffeinated fruit flies help identify potential genes affecting insecticide resistanceDate:March 27, 2014Source:Genetics Society of AmericaSummary:To understand genetic mechanisms underlying insecticide resistance, scientists employed fruit flies and caffeine, a stimulant surrogate for xenobiotics in lab studies on resistance. Crop pests are capable of outwitting the chemical compounds known as xenobiotics that are devised to kill them. This development of resistance to insecticides is a serious problem because it threatens crop production and thereby can influence the availability and costs of many foods as well as the economy.https://www.sciencedaily.com/releases/2014/03/140327101417.htm
Ethanol (including propranolol plus ethanol), haloperidol, pentamidine, quinine, salicylates, and sulfonamides ("sulfa drugs") have been associated with hypoglycemia. Other drugs that may be related to this condition include oral hypoglycemics, phenylbutazone, insulin, bishydroxycoumarin, p-aminobenzoic acid, propoxyphene, stanozolol, hypoglycin, carbamate insecticide, disopyramide, isoniazid, methanol, methotrexate, tricyclic antidepressants, cytotoxic agents, organophosphates, didanosine, chlorpromazine, fluoxetine, sertraline, fenfluramine, trimethoprim, 6-mercaptopurine, thiazide diuretics, thioglycolate, tremetol, ritodrine, disodium ethylenediaminetetraacetic acid (EDTA), clofibrate, angiotensin converting enzyme (ACE) inhibitors, and lithium.https://www.medscape.com/answers/122122-6305/which-drugs-increase-the-risk-of-hypoglycemia-low-blood-sugar
Automimmune Disease
Free Access
Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study
Christine G. Parks, Brian T. Walitt, Mary Pettinger, Jiu-Chiuan Chen … See all authors
First published: 25 August 2010
https://doi.org/10.1002/acr.20335
https://onlinelibrary.wiley.com/doi/full/10.1002/acr.20335
A new study shows that women who are exposed to or use pesticides are more likely to develop lupus and rheumatoid arthritis - two very painful autoimmune diseases. Researchers found that women living on farms who personally handled pesticides were especially at risk of developing these diseases. In fact, they were almost three times more likely to become affected by lupus and rheumatoid arthritis, compared to women who never used pesticides.
https://www.rxwiki.com/news-article/pesticides-linked-increased-risk-lupus-and-rheumatoid-arthritis
Patents for A01N 43 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds (92,096)
03/2013
03/21/2013 CA2845513A1 Method of controlling parasitic weeds with mixtures comprising herbicidal acetolactate synthase inhibitors and plant growth regulators
03/20/2013 EP2570406A1 Plant growth regulating compounds
03/20/2013 EP2570404A1 Plant growth regulating compounds
03/20/2013 EP2570029A1 Fungicidal combination comprising fluoxastrobin and ipconazole
03/20/2013 EP2568812A1 Novel prolylcarboxypeptidase inhibitors
03/20/2013 EP2568811A1 Treatment of mci and alzheimer's disease
03/20/2013 EP2568810A1 Darunavir compositions
03/20/2013 CN1302801B Substituted aminoquinazolone (thio-ketone) derivative or its salt, its intermediate and pest controlling agent and its application method
03/20/2013 CN102985419A Fungicide hydroximoyl-heterocycles derivatives
03/20/2013 CN102985414A Heterocyclic thiosubstituted alkanol derivatives as fungicides
03/20/2013 CN102984943A Improved process for a folate-targeted agent
03/20/2013 CN102984942A Synergistic herbicidal composition containing penoxsulam and butachlor
03/20/2013 CN102984941A Compositions and methods for treatment of leukemia
03/20/2013 CN102984940A Methods for treating methotrexate-resistant disorders with 10-propargyl-10-deazaaminopterin
03/20/2013 CN102984939A Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
03/20/2013 CN102984938A Treatment of MCI and Alzheimer's disease
03/20/2013 CN102977167A Abamectin active pharmaceutical ingredient and pesticide using same as active component
03/20/2013 CN102977166A 13-thioether substituted pleocidin derivative and preparation method thereof
03/20/2013 CN102977079A Pyrrodidone compound containing pyrazole group as well as preparation method thereof and application thereof
03/20/2013 CN102977052A 2-mercaptobenzothiazole manganese zinc as well as preparation method and application of 2-mercaptobenzothiazole manganese zinc
03/20/2013 CN102977036A 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
03/20/2013 CN102977028A Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives
03/20/2013 CN102977011A Process for preparing pyridinamines and novel polymorphs thereof
03/20/2013 CN102976861A Preparation for promoting growth and development of wheat in weak light environment and preparation method thereof
03/20/2013 CN102976860A Post-emergence composite herbicide for corn and application thereof
03/20/2013 CN102972454A Mixture for preventing and controlling aleurodicus dispersus russell
03/20/2013 CN102972453A Novel insecticidal suspending agent containing azadirachtin and neem oil and preparation method for same
03/20/2013 CN102972451A Novel alkaline water
03/20/2013 CN102972450A Plant source compound insecticide
03/20/2013 CN102972449A Novel bactericide
03/20/2013 CN102972448A Disease-resistant composition, and application and suspended seed coating agent thereof
03/20/2013 CN102972442A Bactericide
03/20/2013 CN102972439A Abamectin.fosthiazate slow-release granule and preparation method thereof
03/20/2013 CN102972438A Weeding composition
03/20/2013 CN102972435A Stem latent bud germination promoter and germination promoting method thereof
03/20/2013 CN102972432A Long-lasting insecticide
03/20/2013 CN102972429A Insecticidal composition containing dinotefuran and thiocyclam
03/20/2013 CN102972422A Herbicide containing fluroxypyr, nicosulfuron and atrazine and preparation method thereof
03/20/2013 CN102972421A Insecticidal composition containing emamectin benzoate and triflumuron
03/20/2013 CN102972420A Bactericidal composition containing prothioconazole
03/20/2013 CN102972418A Florasulam water dispersible granules and preparation method thereof
03/20/2013 CN102972417A Compounded herbicide for wheat fields
03/20/2013 CN102972416A Acaricidal composition containing fluacrypyrim and spirodiclofen
03/20/2013 CN102972415A Insecticidal and acaricidal composition containing buprofezin and cyflumetofen
03/20/2013 CN102972414A Bactericidal composition containing triazolone and dimethomorph
03/20/2013 CN102972413A Pyridalyl and flutenzine-containing insecticidal compound
03/20/2013 CN102972412A Novel fruit tree weed composite herbicide and preparation method thereof
03/20/2013 CN102972411A Cornfield herbicide containing butachlor, atrazine and metolachlor
03/20/2013 CN102972410A Pesticide composition containing prothioconazole and methoxyl acrylic ester bactericides
03/20/2013 CN102972409A Seedling-protection micro-emulsion
03/20/2013 CN102972408A Bactericidal composition containing triazolone and fluopicolide
03/20/2013 CN102972407A Novel sanitation and epidemic prevention disinfection smoke agent
03/20/2013 CN102972406A Herbicide composition
03/20/2013 CN102972405A Herbicide composition for soybean field
03/20/2013 CN102972404A Pesticidal composition containing fluacrypyrim and cyflumetofen
03/20/2013 CN102972403A Environmental-friendly aliphatic ester insecticide
03/20/2013 CN102972402A Kasugamycin-containing pesticide composition
03/20/2013 CN102972401A 2, 5-diphenylthiophene nano microcapsule preparation for preventing lygocoris lucorum and method for preparing 2, 5-diphenylthiophene nano microcapsule preparation for preventing lygocoris lucorum
03/20/2013 CN102972395A 2, 5-bithiophene-2-ethinyl thiophene nano microcapsule preparation for preventing lygocoris lucorum and method for preparing 2, 5-bithiophene-2-ethinyl thiophene nano microcapsule preparation for preventing and treating lygocoris lucorum
03/20/2013 CN102972393A Agricultural weeding earth membrane capable of being completely biodegraded
03/20/2013 CN102612935B Application method of wheat
03/20/2013 CN102365948B Chitosan oligosaccharide composition for resisting rice blast, application and method thereof
03/20/2013 CN102265869B Herbicidal composition containing bentazone, dicamba and sulcotrione and application thereof
03/20/2013 CN102177898B Application of 2-arylmorpholine and salt thereof serving as insecticide
03/20/2013 CN102150682B Application of decursin as agricultural insecticide
03/20/2013 CN102119700B Synergetic antibacterial composition containing fluazinam and iprobenfos and use thereof
03/20/2013 CN102119694B Synergetic antibacterial composition containing fluazinam and diniconazole and use thereof
03/20/2013 CN102119693B Synergetic antibacterial composition containing fluazinam and tebuconazole and use thereof
03/20/2013 CN102119687B Synergistic bactericidal composition containing fluazinam and isoprothiolane and application thereof
03/20/2013 CN102119684B Bactericidal composition containing fluazinam and dimethachlon and application of same
03/20/2013 CN102113513B Pesticide composition containing chlorfenapyr and profenofos
03/20/2013 CN102113510B Insecticidal composition containing metaflumizone
03/20/2013 CN102067871B Pill for preventing and treating maize borer and corncob aphid insect damage and realizing corn height control
03/20/2013 CN102057917B Fungicidal combinations
03/20/2013 CN102057915B Chemical control preparation for enhancing stress resistance and seed yield of wheats and application thereof
03/20/2013 CN102007921B Composition containing fenoxaprop-p-ethyl and fluroxypyr-meptyl and application thereof
03/20/2013 CN101965848B Biogenic pesticide for efficiently preventing and controlling main diseases of Camellia oleifera and application thereof
03/20/2013 CN101961010B Absorbent disinfection dry powder and preparation method thereof
03/20/2013 CN101828553B Pesticide composition for regulating corn growth
03/20/2013 CN101779660B Sterilization composition containing methyram
03/20/2013 CN101779636B Bactericidal composite containing tetraconazole
03/20/2013 CN101772486B Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
03/20/2013 CN101755832B Ultra-low volume combination medicament for controlling rice-stem borer
03/20/2013 CN101755825B Bactericide composition containing thifluzamide
03/20/2013 CN101755769B Fenazaquin-containing synergic pesticide composition
03/20/2013 CN101743979B Bactericidal composite with active ester
03/20/2013 CN101731274B Seed treatment agent suitable for strengthening seedlings of rapes and increasing pod numbers
03/20/2013 CN101703042B Plant bactericidal milk particles and preparation method thereof
03/20/2013 CN101669491B Pesticide emulsion and preparation method thereof
03/20/2013 CN101627767B Emulsion in water containing lufenuron and preparation method thereof
03/20/2013 CN101508692B Anthranilamides, process for the production thereof, and pest controllers containing the same
03/20/2013 CN101410013B Active ingredient combinations with insecticidal and acaricidal properties
03/20/2013 CN101400259B Method of inducing tolerance of plants against bacterioses
03/20/2013 CN101228879B Herbicidal compositions comprising n-[(4,6-dimethoxypyridin-2-yl)aminocarbonyl]-5-methylsulphonamidomethyl-2-alkoxycarbonylbenzene sulphonamides
03/20/2013 CN101218915B Pesticidal composition
03/20/2013 CN101199274B Bactericide composition and method for controlling plant disease
03/19/2013 US8399635 Chitosan derivatives to treat animals or optimize animal health
03/19/2013 US8399510 Method of activating NK cells
03/19/2013 US8399506 Combinations of 4 bromo-2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and oxidizing agents
03/19/2013 US8399498 Animal ectoparasite-controlling agent
https://www.google.com/patents/sitemap/en/Sitemap/A01/A01N/A01N_43_138.html
An enzyme inhibitor is a molecule that binds to an enzyme and decreases its activity. By binding to enzymes' active sites, inhibitors reduce the compatibility of substrate and enzyme and this leads to the inhibition of Enzyme-Substrate complexes' formation, preventing the catalysis of reactions and decreasing (at times to zero) the amount of product produced by a reaction. It can be said that as the concentration of enzyme inhibitors increases, the rate of enzyme activity decreases, and thus, the amount of product produced is inversely proportional to the concentration of inhibitor molecules. Since blocking an enzyme's activity can kill a pathogenor correct a metabolic imbalance, many drugs are enzyme inhibitors. They are also used in pesticides. Not all molecules that bind to enzymes are inhibitors; enzyme activators bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
Effects of avermectin on immune function and oxidative stress in the pigeon spleen.
Organophosphate poisoning is an important cause of acute neurological dysfunction and respiratory distress.
Epidemiology
Organophosphate poisoning is common, often as a result of suicidal ingestion (acute high-level exposure) or occupational exposure to pesticides (chronic low-level exposure) 1. It is thought that worldwide, approximately 3 million people are exposed to toxic levels of organophosphates, including approximately 2 million hospitalizations for suicidal ingestion 1.
Clinical presentation
Acute organophosphate poisoning leads to three distinct sequential neurological syndromes.
- acute cholinergic crisis and paralysis (type I paralysis)
- it is characterized by an acute muscarinic syndrome that manifests within hours of initial toxic exposure, and is soon afterwards followed by an acute nicotinic syndrome 2,3
- the features of the muscarinic syndrome are helpfully summarized by the popular mnemonic 'SLUDGEM-BBB': salivation, lacrimation, urination, diarrhea, gastric cramps, emesis, miosis, bronchorrhea, bronchospasm, bradycardia 2
- the features of the nicotinic syndrome are not in the mnemonic (and thus are often forgotten) but include fasciculations and muscle weakness 2
- seizures may also occur acutely 2
- intermediate syndrome (type II paralysis)
- this is a continuation or extension of the nicotinic syndrome that manifests days after initial toxic exposure 2,3
- it is characterized by continued paralysis, with prominent involvement of neck flexors, ocular muscles, bulbar muscles, and respiratory muscles 2,3
- some patients may also exhibit extrapyramidal symptoms (e.g. parkinsonism, choreoathetosis) 2,3
- organophosphate-induced delayed polyneuropathy (type III paralysis)
- this is an uncommon syndrome that occurs weeks after initial toxic exposure 2,3
- it is characterized by a symmetric and predominantly motor axonal neuropathy leading to flaccid limb weakness 2
With chronic exposure to low-dose organophosphates, the chronic organophosphate-induced neuropsychiatric disorder may manifest 4. This is characterized by fatigue, memory impairment, extrapyramidal symptoms, autonomic dysfunction, and peripheral neuropathy 4. Interestingly, cholinergic symptoms of a muscarinic syndrome are not a feature of chronic low-dose exposure 4.
Pathology
Organophosphates are agents that bind to acetylcholinesterase and inhibit its action of normally hydrolyzing acetylcholine 2,5. Acetylcholine is a neurotransmitter that is found at neuronal synapses and neuromuscular junctions, and acts on acetylcholine receptors, namely the muscarinic (mAChR) and nicotinic acetylcholine receptors (nAChR) 2,5.
Muscarinic acetylcholine receptors are predominantly involved in the activation of the parasympathetic nervous system, but are also found in the central nervous system 2,5. Nicotinic acetylcholine receptors are located at the neuromuscular junction (muscle-type nicotinic acetylcholine receptors), but also upstream in the central and peripheral nervous systems (neuronal-type nicotinic acetylcholine receptors) 2,5.
In acute organophosphate poisoning, there is overactivation of both muscarinic and nicotinic receptors, resulting in the acute muscarinic and nicotinic syndromes, as described above 2. The intermediate syndrome is a sequelae of the acute nicotinic syndrome, and is due to a depletion in acetylcholine at the neuromuscular junction 2. Additionally, in the basal ganglia, this results in a neurotoxicity and relative dopamine excess, which accounts for the extrapyramidal symptoms that are sometimes also seen in the intermediate syndrome 6. Neurotoxicity disproportionally affects the basal ganglia due to their high metabolic demand and rich vasculature 6.
The mechanism underlying organophosphate-induced delayed polyneuropathy is not well understood, but is thought to be independent to the functioning of both muscarinic and nicotinic receptors, and may be due to inhibition of the enzyme neurotoxic esterase instead 2. Similarly, the mechanism behind the chronic organophosphate-induced neuropsychiatric disorder is also poorly understood 4.
Radiographic features
Imaging is generally only remarkable in the brain (the focus of this section), however some patients may also develop a chemical aspiration pneumonitis which may produce findings on chest imaging 7. Generally, brain imaging findings only become apparent during the intermediate syndrome, and are reversible within weeks.
CT
CT brain may show hypoattenuation bilaterally in the basal ganglia 8. Generally, and unlike other toxic encephalopathies, these areas do not show evidence of hyperattenuating macroscopic hemorrhage.
MRI
Similar to CT, symmetric and bilateral involvement of the basal ganglia may be appreciated on MRI brain during the intermediate syndrome 3,6. In particular, the putamen and caudate nucleiare predominantly affected 3,6. Signal characteristics include 3,6:
- T1: low signal
- T2/FLAIR: high signal
- T1 C+ (Gd): usually minimal or absent contrast enhancement
- DWI: increased diffusion signal
Two case reports have also described lesions, with the same signal characteristics, in the cerebellum 3,9. Additionally, one case study has described an eye of the tiger sign in a case of organophosphate poisoning, whereby there was central T2 high signal with a low signal rim in the globus pallidus bilaterally, suggestive of a hemorrhagic necrosis 10. It is likely that these are atypical radiographic manifestations of acute organophosphate poisoning.
Importantly, all signal changes completely resolve within weeks to months 6. Unlike other toxic encephalopathies, such as methanol poisoning, cystic sequelae usually do not eventuate 6.
Treatment and prognosis
Acute management is generally with resuscitation and pharmacotherapy such as atropine, an agent that competes with acetylcholine at muscarinic receptors, and pralidoxime, an agent that reactivates acetylcholinesterases at both the muscarinic and nicotinic receptors 2. This acute care often takes place in an intensive care unit 2.
There is currently no treatment for the intermediate syndrome or organophosphate-induced delayed polyneuropathy, and patients with those manifestations should be managed symptomatically 2,4.
Differential diagnosis
For involvement in and around the basal ganglia, consider:
- mitochondrial encephalopathies
- other toxic encephalopathies
- metabolic disorders
- prion encephalopathies
No comments:
Post a Comment